S12 Flashcards
(18 cards)
What is the maximum interval your responsible pharmacist should leave for reviewing the pharmacy procedures?
1 month
2 months
6 months
1 year
2 years
3 years
5 years
10 years
2 years
What is the legal requirement for how long the Responsible Pharmacist record be kept for from the date of the last entry?
1 month
2 months
6 months
1 year
2 years
3 years
5 years
10 years
5 years
What is the legal requirement for how long the CD register should be kept for from the date of last entry?
1 month
2 months
6 months
1 year
2 years
3 years
5 years
10 years
2 years
You have received a hand written FP10 prescription from a GP. It is not for a controlled drug. The doctor has failed to include the strength on the prescription. The product comes in one strength. What is your best course of action?
Ask the dispenser what you’ve got on the shelf and dispense that
Ask the doctor’s receptionist what strength to give
Ask the patient to return to the prescriber to get the strength added
Ask the patient what strength they usually have
Contact the prescriber to clarify the strength and add a ‘PC’ endorsement to the prescription
Dispense the prescription with no additional actions
Dispense the strength available and endorse the prescription accordingly
Use your professional judgement about which strength to dispense
Dispense the strength available and endorse the prescription accordingly
The product strength is not a legal requirement on this prescription, but appropriate actions should be taken to dispense the correct product. Where only one strength is available that can be dispensed and the prescription endorsed accordingly.
You have received a hand written FP10 prescription from a GP. It is not for a controlled drug. The doctor has failed to include the strength on the prescription. The product comes in more than one strength. What is your best course of action?
Ask the dispenser what you’ve got on the shelf and dispense that
Ask the doctor’s receptionist what strength to give
Ask the patient to return to the prescriber to get the strength added
Ask the patient what strength they usually have
Contact the prescriber to clarify the strength and add a ‘PC’ endorsement to the prescription
Dispense the prescription with no additional actions
Dispense the strength available and endorse the prescription accordingly
Use your professional judgement about which strength to dispense
Contact the prescriber to clarify the strength and add a ‘PC’ endorsement to the prescription
The product strength is not a legal requirement on this prescription, but appropriate actions should be taken to dispense the correct product. Where more than one strength is available the prescriber should be contacted for clarification and the prescription endorsed accordingly.
ou have received a hand written FP10 prescription from a GP. It is not for a controlled drug. The doctor has included the strength of the preparation on the prescription. The product does not come in that strength but you note that the marketed strengths available are all lower in strength and you can use these to make the requested strength. What is your best course of action?
Ask the dispenser what you’ve got on the shelf and dispense that
Ask the doctor’s receptionist what strength to give
Ask the patient to return to the prescriber to get the strength added
Ask the patient what strength they usually have
Contact the prescriber to clarify the strength and add a ‘PC’ endorsement to the prescription
Dispense the prescription with no additional actions
Dispense the strength available and endorse the prescription accordingly
Use your professional judgement about which strength to dispense
Use your professional judgement about which strength to dispense
The product strength is not a legal requirement on this prescription, but appropriate actions should be taken to dispense the correct product. Where the strength prescribed does not exist, professional judgement should be used to make the strength using lower strengths. Where this cannot be done, the prescriber should be contacted for guidance
Which medicine decreases gluconeiogenesis by increasing peripheral utilisation of glucose?
Acarbose
Empagliflozin
Exenatide
Gliclazide
Metformin
Repaglinide
Saxagliptin
Short-acting insulin
Metformin
Which medicine delays the digestion and absorption of starch and sucrose?
Acarbose
Empagliflozin
Exenatide
Gliclazide
Metformin
Repaglinide
Saxagliptin
Short-acting insulin
Acarbose
Which medicine inhibits dipeptidylpeptidase-4 to increase insulin secretion and lower glucagon secretion?
Acarbose
Empagliflozin
Exenatide
Gliclazide
Metformin
Repaglinide
Saxagliptin
Short-acting insulin
Saxagliptin
Which medicine binds to and activates the GLP-1 (glucagon-like peptide-1) receptor to increase insulin secretion, suppress glucagon secretion and slow gastric emptying?
Acarbose
Empagliflozin
Exenatide
Gliclazide
Metformin
Repaglinide
Saxagliptin
Short-acting insulin
Exenatide binds to and activates the GLP-1 (glucagon-like peptide-1) receptor to increase insulin secretion, suppress glucagon secretion and slow gastric emptying.
A small increase in the dose can produce a dramatic change in the plasma levels of this drug.
Amiodarone
Clozapine
Digoxin
Gentamicin
Lithium
Phenytoin
Theophylline
Warfarin
Phenytoin
Phenytoin is approximately 90% bound to plasma proteins, and metabolised in the liver. At low concentrations, elimination is proportional to the concentration. However, as the concentration rises to therapeutic levels, the enzyme system in the liver can become saturated and elimination occurs at a constant rate despite the dose (zero order kinetics). The effect is that a small increase in the dose sometimes causes a large change in the level of free phenytoin in the blood.
Patients of Chinese ancestry are more likely to be associated with developing Stevens-Johnson syndrome.
Amiodarone
Clozapine
Digoxin
Gentamicin
Lithium
Phenytoin
Theophylline
Warfarin
Phenytoin
Evidence (although limited) suggests that HLA-B* 1502 may be a risk factor for the development of SJS/TEN in patients of Asian ancestry taking drugs associated with SJS/TEN, including phenytoin.
Patients should be carefully evaluated clinically and consideration given to chest X-rays before starting therapy.
Amiodarone
Clozapine
Digoxin
Gentamicin
Lithium
Phenytoin
Theophylline
Warfarin
Amiodarone
Amiodarone can be associated with serious and sometimes fatal lung toxicity. X-ray before starting to establish baseline, after that annually to monitor any changes.
Symptoms of mild overdose may include blurred vision, light headedness, fine resting tremor, muscular weakness and drowsiness.
Amiodarone
Clozapine
Digoxin
Gentamicin
Lithium
Phenytoin
Theophylline
Warfarin
Lithium
Blurred vision, resting tremor, muscular weakness etc are characteristics to lithium intoxication
The patient should have their white blood cell (WBC) counts and absolute neutrophil count (ANC) checked weekly for the first 18 weeks.
Amiodarone
Clozapine
Digoxin
Gentamicin
Lithium
Phenytoin
Theophylline
Warfarin
Clozapine
Neutropenia and potentially fatal agranulocytosis reported with clozapine. Leucocyte and differential blood counts must be normal before starting; monitor counts every week for 18 weeks then at least every 2 weeks and if clozapine continued and blood count stable after 1 year at least every 4 weeks (and 4 weeks after discontinuation); if leucocyte count below 3000 /mm3 or if absolute neutrophil count below 1500 /mm3 discontinue permanently and refer to haematologist.
Mr D started to feel generally unwell a week ago and had a tingling feeling on the left side of his trunk associated with back pain. A band-like rash appeared in that same area a few days later . He described the rash as red and blotchy, developing into fluid filled blisters, which then dried out and formed scabs.
Allergic reaction
Chickenpox
Eczema
Impetigo
Psoriasis
Scabies
Shingles
Urticaria
Shingles
The symptoms described are those of shingles. Note that if the rash appears on both sides of the body, it is unlikely to be shingles. Also although the rash associated with shingles usually appears on the trunk it could also affect other areas of the body, such as the face, eyes and genitals.
All of the persons living with the individual who presents with this should be treated.
Allergic reaction
Chickenpox
Eczema
Impetigo
Psoriasis
Scabies
Shingles
Urticaria
Scabies
When one individual has scabies everyone in the household needs to be treated at the same time, even if they don’t have symptoms.
Miss E comes into your pharmacy. She is a nurse at the local nursing home. She tells you that she has noticed that one of the residents has been complaining of severe itchy hands, particularly at night. She examined the patient’s hands and noticed silver lines with a dot at the end in the webs of her fingers.
Allergic reaction
Chickenpox
Eczema
Impetigo
Psoriasis
Scabies
Shingles
Urticaria
Scabies
The symptoms described are those of an early infection of scabies. The mites lay eggs under the skin which leave these silver lines in the hand. This can develop into a rash and the rash can spread and turn into spots.
